# Relationship between Postoperative Complications and Ratio of Amount of Wetting Solution to Ideal Body Weight in Liposuction Procedures

**Authors:** Serap Aktas Yildirim, Lerzan Dogan, Zeynep Tugce Sarikaya, Bulent Gucyetmez, Yener Demirtas, Fevzi Toraman

PMC · DOI: 10.3390/jpm14050494 · 2024-05-07

## TL;DR

This study found that using more than 90 mL/kg of wetting solution during liposuction increases the risk of certain postoperative complications like nausea and hypertension.

## Contribution

The study identifies a specific threshold (90 mL/kg) for wetting solution volume related to increased postoperative complications in liposuction.

## Key findings

- Patients receiving >90 mL/kg of wetting solution had a 5.3-fold higher risk of postoperative nausea.
- Hypertension risk increased 4.9-fold in patients receiving >90 mL/kg of wetting solution.
- Hypothermia risk was 4.2-fold higher in the higher wetting solution group.

## Abstract

Background: The use of wetting solutions (WSs) during high-volume liposuction is standard; however, the optimal amount of WS and its components and their effect on postoperative complications are unclear. We evaluated the effect of a WS and its components, calculated according to ideal body weight (IBW), on postoperative complications. Methods: High-volume liposuction with a WS containing 0.5 g of lidocaine and 0.5 mg of epinephrine in each liter was performed in 192 patients. Patients who received ≤90 mL/kg of WS were designated as group I and those who received >90 mL/kg of WS as group II. Postoperative complications and adverse events that occurred until discharge were recorded. Results: The mean total amount of epinephrine in the WS was significantly higher for group II (3.5 mg; range, 3.0–4.0 mg) than for group I (2.0 mg; range, 1.8–2.5 mg; p < 0.001), as was the mean total amount of lidocaine (3.5 g [range, 3.5–4.3 g] vs. 2.0 g [range, 1.8–2.5 g], respectively; p < 0.001). No major cardiac or pulmonary complications occurred in either group. Administration of >90 mL/kg of WS increased the median risk of postoperative nausea 5.3-fold (range, 1.8- to 15.6-fold), that of hypertension 4.9-fold (range, 1.1- to 17.7-fold), and that of hypothermia 4.2-fold (range, 1.1- to 18.5-fold). The two groups had similar postoperative pain scores and blood transfusion rates. Conclusions: The risks of postoperative nausea, vomiting, hypothermia, and hypertension may increase in patients who receive >90 mL/kg of WS calculated according to IBW during high-volume liposuction.

## Linked entities

- **Chemicals:** lidocaine (PubChem CID 3676), epinephrine (PubChem CID 838)

## Full-text entities

- **Diseases:** WS (MESH:D018980), Postoperative Complications (MESH:D011183), hypertension (MESH:D006973), hypothermia (MESH:D007035), postoperative nausea (MESH:D020250), cardiac or pulmonary complications (MESH:D006331), postoperative pain (MESH:D010149)
- **Chemicals:** lidocaine (MESH:D008012), epinephrine (MESH:D004837), WS (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11121857